ETV1 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant ETV1.
|Application ||WB, E|
|Calculated MW||55131 Da|
|Other Names||ETS translocation variant 1, Ets-related protein 81, ETV1, ER81|
|Target/Specificity||ETV1 (NP_004947, 148 a.a. ~ 257 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||ETV1 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
An oncogenic role for ETV1 in melanoma. Jan?-Valbuena J, et al. Cancer Res, 2010 Mar 1. PMID 20160028.Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. Reid AH, et al. Br J Cancer, 2010 Feb 16. PMID 20104229.Induction of prostatic intraepithelial neoplasia and modulation of androgen receptor by ETS variant 1/ETS-related protein 81. Shin S, et al. Cancer Res, 2009 Oct 15. PMID 19789348.Transcriptional activation of hTERT in breast carcinomas by the Her2-ER81-related pathway. Vageli D, et al. Oncol Res, 2009. PMID 19718948.Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma. Han B, et al. Mod Pathol, 2009 Sep. PMID 19465903.
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.